Prevalence of Lung Cancer Screening in the US, 2022 is a research paper published in JAMA Network Open (2024). On theSindex it has a DataRank of 0. It has been cited 110 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA251686
NCI NIH HHS
Grant: R01 CA277756
NCI NIH HHS
Grant: R01 CA212014
National Institutes of Health
Grant: 3R01CA277756-02S1
Applying causal inference methods to improve estimation of the real-world benefits and harms of lung cancer screening - NCI Diversity Supplement
European Commission
Grant: 251686
INCORPORATING EUROPEAN FUNDAMENTAL VALUES INTO ICT FOR AGEING: A VITAL POLITICAL, ETHICAL , TECHNOLOGICAL, AND INDUSTRIAL CHALLENGE
National Institutes of Health
Grant: 1R01CA251686-01
Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening
FWCI
32.18
Citation Percentile
1.0%
Influential Citations
5
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals